Science Explorer Back to mapMap

Schizophrenia research and treatment

Schizophrenia research and treatment is a research topic within Psychiatry and Mental health. Science Explorer counts 58k research works in it since 1950. 9.9% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the research, treatment, and various aspects of schizophrenia, including the effectiveness of antipsychotic drugs, neurocognitive deficits, genetic association studies, metabolic syndrome, neurodevelopmental models, cognitive therapy, social cognition, prodromal symptoms, dopamine dysfunction, and neuroanatomical abnormalities in individuals with schizophrenia.

  • Antipsychotic Drugs
  • Neurocognitive Deficits
  • Genetic Association Studies
  • Metabolic Syndrome
  • Neurodevelopmental Model
  • Cognitive Therapy
  • Social Cognition
  • Prodromal Symptoms
  • Dopamine Dysfunction
  • Neuroanatomical Abnormalities
Research works
58k
fractional, since 1950
In the world top 10%
5.7k
per year above
Top-10% rate
9.9%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+3%
the tick is no change
Largest producer
United States
32% of the 10 largest, 2022-now
Schizophrenia research and treatment

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Schizophrenia research and treatment research?

By volume, the United States and the United Kingdom publish the most (2.1k and 889 works in 2022-now).

By volume, 2022-now

  1. 1 United States 2.1k works
  2. 2 United Kingdom 889 works
  3. 3 China 884 works
  4. 4 Spain 453 works
  5. 5 Canada 427 works
  6. 6 Germany 415 works
  7. 7 India 381 works
  8. 8 Australia 368 works
  9. 9 Italy 355 works
  10. 10 Japan 285 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 31.5%United Kingdom: 13.7%China: 13.6%Spain: 7.0%6 others listed: 34.3%32%largest
United States2,050 · 31.5%United Kingdom889 · 13.7%China884 · 13.6%Spain453 · 7.0%6 others listed2,232 · 34.3%

Shares of the rows listed above, not of the whole node.

Which institutions lead Schizophrenia research and treatment research?

By volume in 2022-now, Harvard University publishes the most Schizophrenia research and treatment research, followed by University of Toronto and University of North Carolina at Chapel Hill.

Who are the leading researchers in Schizophrenia research and treatment?

The most-cited researchers publishing on Schizophrenia research and treatment include Christopher J L Murray, Simon Iain Hay and Theo Vos.

  1. 1 Christopher J L Murray United States 583k citations
  2. 2 Simon Iain Hay United States 452k citations
  3. 3 Theo Vos United States 439k citations
  4. 4 George Davey Smith United Kingdom 435k citations
  5. 5 Ali H. Mokdad United States 429k citations
  6. 6 Mark J. Daly United States 403k citations
  7. 7 Richard M. Ryan United States 395k citations
  8. 8 Ronald C. Kessler United States 360k citations
  9. 9 Cyrus Cooper United Kingdom 342k citations
  10. 10 Jun Wang China 340k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Schizophrenia research and treatment?

The most cited paper in Schizophrenia research and treatment is "The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia" (Stanley R. Kay, Abraham Fiszbein, Lewis A. Opler, 1987), with 21,651 citations. Next come "Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication" (20,746) and "An inventory for measuring clinical anxiety: Psychometric properties." (10,944).

Most cited papers
#PaperReleasedCitations
1 The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia Stanley R. Kay, Abraham Fiszbein, Lewis A. Opler · Schizophrenia Bulletin Open access 1987 21,651
2 Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication Ronald C. Kessler, Patricia A. Berglund, Olga Demler et al. · Archives of General Psychiatry Jun 2005 20,746
3 An inventory for measuring clinical anxiety: Psychometric properties. Aaron T. Beck, Norman B. Epstein, Gary P. Brown et al. · Journal of Consulting and Clinical Psychology 1988 10,944
4 Short screening scales to monitor population prevalences and trends in non-specific psychological distress Ronald C. Kessler, Gavin Andrews, Lisa J. Colpe et al. · Psychological Medicine Aug 2002 10,488
5 The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. David V. Sheehan, Yves Lecrubier, Sheehan Kh et al. · PubMed 1998 10,266
All 100 most cited papers, with filters and sorting

Where is Schizophrenia research and treatment research done?

The largest centres of Schizophrenia research and treatment research in 2022-now are London (United Kingdom), New York (United States), Beijing (China) and Toronto (Canada).

Largest cities, 2022-now

  1. 1 LondonUnited Kingdom 313 works
  2. 2 New YorkUnited States 140 works
  3. 3 BeijingChina 131 works
  4. 4 TorontoCanada 113 works
  5. 5 MelbourneAustralia 102 works
  6. 6 MadridSpain 99 works
  7. 7 BarcelonaSpain 99 works
  8. 8 MontrealCanada 93 works
  9. 9 CopenhagenDenmark 89 works
  10. 10 BostonUnited States 87 works
See Schizophrenia research and treatment on the map

Where is the best place to study Schizophrenia research and treatment?

Among universities, judged by research, King's College London, University of Oxford and Harvard University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 16.91%fractional works in this field (log) →share of work in the world top 10% →King's College LondonUniversity of Copenh…University of OxfordHarvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1King's College LondonUnited Kingdom 75.318.6%11.9×84 -28.0%
2University of OxfordUnited Kingdom 71.614.8%3.5×41 +34.7%
3Harvard UniversityUnited States 71.313.2%4.5×117 -3.3%
4University of CopenhagenDenmark 70.015.6%7.4×57 +7.4%
5Technical University of MunichGermany 68.224.2%2.4×17 +41.4%
6University College LondonUnited Kingdom 64.916.4%3.8×50 -15.0%
7McGill UniversityCanada 64.012.3%6.7×55 +15.3%
8Aarhus UniversityDenmark 62.715.4%3.7×27 +35.1%
9Emory UniversityUnited States 61.419.6%3.9×26 +18.2%
10Karolinska InstitutetSweden 61.219.0%6.0×28 -26.1%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Schizophrenia research and treatment, country by country

Is Schizophrenia research and treatment research growing?

Output in 2022-2025 was 3% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Schizophrenia research and treatment.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Schizophrenia research and treatment as a percentage of every work published that year, 0.037% in 2024.

still counting0.050%0.10%Schizophrenia research and treatment0.041% in 202519801990200020102020

Fractional works of Schizophrenia research and treatment over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Schizophrenia research and treatment9.8% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Questions people ask

Who is researching a cure for schizophrenia?

By volume in 2022-now, Harvard University publishes the most Schizophrenia research and treatment research, followed by University of Toronto and University of North Carolina at Chapel Hill. By volume, the United States and the United Kingdom publish the most (2.1k and 889 works in 2022-now).

How much research is there on schizophrenia, and is it growing?

Output in 2022-2025 was 3% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Schizophrenia research and treatment.

Is Schizophrenia research and treatment research growing?
All 1,273 questions in the Question Catalogue

Discussion

Ask a question or share a note about Schizophrenia research and treatment. Posts are plain text and can be reported.